Efficacy of Histone Deacetylase and Estrogen Receptor Inhibition in Breast Cancer Cells Due to Concerted down Regulation of Akt
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of Histone Deacetylase and Estrogen Receptor Inhibition in Breast Cancer Cells Due to Concerted down Regulation of Akt
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 7, Pages e68973
Publisher
Public Library of Science (PLoS)
Online
2013-07-10
DOI
10.1371/journal.pone.0068973
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase I study of the safety, pharmacokinetics (PK) and pharmacodynamics (PD) of the histone deacetylase inhibitor (HDACi) PCI-24781
- (2017) S. D. Undevia et al. JOURNAL OF CLINICAL ONCOLOGY
- Invasive Breast Cancer
- (2017) Robert W. Carlson et al. Journal of the National Comprehensive Cancer Network
- Histone Deacetylase 3 Suppression Increases PH Domain and Leucine-rich Repeat Phosphatase (Phlpp)1 Expression in Chondrocytes to Suppress Akt Signaling and Matrix Secretion
- (2013) Elizabeth W. Bradley et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Histone deacetylase 1 enhances microRNA processing via deacetylation of DGCR8
- (2012) Taeko Wada et al. EMBO REPORTS
- Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study
- (2012) Thomas Bachelot et al. JOURNAL OF CLINICAL ONCOLOGY
- Addition of a histone deacetylase inhibitor redirects tamoxifen-treated breast cancer cells into apoptosis, which is opposed by the induction of autophagy
- (2011) Scott Thomas et al. BREAST CANCER RESEARCH AND TREATMENT
- Preclinical evaluation of dual PI3K-mTOR inhibitors and histone deacetylase inhibitors in head and neck squamous cell carcinoma
- (2011) R B Erlich et al. BRITISH JOURNAL OF CANCER
- A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer
- (2011) P N Munster et al. BRITISH JOURNAL OF CANCER
- miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression
- (2011) Jian Li et al. CANCER LETTERS
- Gefitinib or Placebo in Combination with Tamoxifen in Patients with Hormone Receptor-Positive Metastatic Breast Cancer: A Randomized Phase II Study
- (2011) C. K. Osborne et al. CLINICAL CANCER RESEARCH
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epigenetic modulation: a novel therapeutic target for overcoming hormonal therapy resistance
- (2011) Paromita Raha et al. Epigenomics
- MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2
- (2010) Niamh H Foley et al. Molecular Cancer
- Blockade of the ERK or PI3K–Akt signaling pathway enhances the cytotoxicity of histone deacetylase inhibitors in tumor cells resistant to gefitinib or imatinib
- (2009) Kei-ichi Ozaki et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Histone deacetylase inhibitor induced modulation of anti-estrogen therapy
- (2009) Scott Thomas et al. CANCER LETTERS
- Selective Inhibition of Histone Deacetylase 2 Silences Progesterone Receptor-Mediated Signaling
- (2008) E. Bicaku et al. CANCER RESEARCH
- An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer
- (2008) K. Stemke-Hale et al. CANCER RESEARCH
- Histone deacetylase inhibitor SAHA induces ERα degradation in breast cancer MCF-7 cells by CHIP-mediated ubiquitin pathway and inhibits survival signaling
- (2007) Xin Yi et al. BIOCHEMICAL PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search